CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- FinancialsAltman Z-Score 9.8: safe zone
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.79%Below 5Y avg (0.98%)
Annual Rate
CNY 0.05Paid annual
Payout Ratio
32.3%Sustainable
Last Ex-Dividend
May 26, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.01BCNY298.52M · vs all stocks (USD)
Trailing P/E
29.68xRevenue (TTM)
437.17MCNY64.93M · vs all stocks (USD)
Profit Margin
14.53%Beta
0.2380xvs all stocks
52-Week Change
-17.34%vs all stocks
Market Capitalization
2.01BCNY298.52M · vs all stocks (USD)
Enterprise Value
1.88BCNY279.03M · vs all stocks (USD)
Trailing P/E
29.68xPrice to Sales (TTM)
4.47xPrice to Book (MRQ)
2.00xEnterprise to Revenue
4.30xEnterprise to EBITDA
17.97xGross Margin
33.09%Profit Margin
14.53%Operating Margin
17.65%Return on Assets (TTM)
3.28%Return on Equity (TTM)
6.62%Revenue (TTM)
437.17MCNY64.93M · vs all stocks (USD)
Revenue per Share (TTM)
1.51CNYUpdated Aug 20, 2026Quarterly Revenue Growth
-19.50%Gross Profit (TTM)
131.75MCNY19.57M · vs all stocks (USD)
EBITDA (TTM)
80.15MCNY11.90M · vs all stocks (USD)
Net Income (TTM)
63.51MCNY9.43M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-7.80%Operating Cash Flow (TTM)
71.62MCNY10.64M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
58.55MCNY8.70M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.0530CNYUpdated Aug 20, 2026Trailing Annual Dividend Yield
0.79%vs all stocks
5-Year Average Dividend Yield
0.98%vs all stocks
Payout Ratio
32.27%Minority Interest (Equity)
1.42MCNYFY2025 · Dec 31, 2025Revenue
460.42MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
323.47MCNYFY2025 · Dec 31, 2025Gross Profit
136.96MCNYFY2025 · Dec 31, 2025Operating Income
65.67MCNY9.75M · vs all stocks (USD)
Pre-tax Income
74.44MCNYFY2025 · Dec 31, 2025Income Tax Expense
9.33MCNYFY2025 · Dec 31, 2025Net Income
65.11MCNYFY2025 · Dec 31, 2025EBIT
74.45MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
124.85MCNYFY2025 · Dec 31, 2025Research & Development
12.65MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
27.87MCNYFY2025 · Dec 31, 2025Other Operating Expenses
4.41MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
12.40MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
13.28KCNYFY2025 · Dec 31, 2025Net Income from Continuing Operations
65.11MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-126.61KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
61.68MCNYFY2025 · Dec 31, 2025Free Cash Flow
57.82MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
80.02MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
65.11MCNYFY2025 · Dec 31, 2025Other Non-cash Items
-10.17MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-15.64MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
22.38MCNYFY2025 · Dec 31, 2025Capital Expenditures
-3.86MCNYFY2025 · Dec 31, 2025Sale of Investments
22.54MCNYFY2025 · Dec 31, 2025Other Investing Activity
-87.49MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-68.81MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-29.31MCNYFY2025 · Dec 31, 2025Other Financing Charges
-656.36KCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-29.97MCNYFY2025 · Dec 31, 2025Shares Outstanding
299.10MSharesUpdated Aug 20, 2026Float Shares
173.65MSharesUpdated Aug 20, 2026% Held by Insiders
45.31%vs all stocks
% Held by Institutions
4.66%vs all stocks
Total Cash (MRQ)
108.56MCNY16.12M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.3630CNYUpdated Aug 20, 2026Total Debt (MRQ)
21.45KCNY3.19K · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0000xCurrent Ratio (MRQ)
3.08xBook Value per Share (MRQ)
3.27CNYUpdated Aug 20, 2026Total Assets
1.11BCNY164.54M · vs all stocks (USD)
Total Current Assets
399.79MCNYFY2025 · Dec 31, 2025Total Liabilities
146.37MCNYFY2025 · Dec 31, 2025Total Non-current Assets
708.10MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
15.19MCNYFY2025 · Dec 31, 2025Total Current Liabilities
131.18MCNYFY2025 · Dec 31, 2025Cash
155.47MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
155.47MCNYFY2025 · Dec 31, 2025Accounts Receivable
126.87MCNYFY2025 · Dec 31, 2025Inventory
75.76MCNYFY2025 · Dec 31, 2025Accounts Payable
91.26MCNYFY2025 · Dec 31, 2025Short-term Debt
21.61KCNYFY2025 · Dec 31, 2025Other Current Liabilities
105.22KCNYFY2025 · Dec 31, 2025Common Stock (Book)
299.10MCNYFY2025 · Dec 31, 2025Retained Earnings
500.10MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
961.52MCNY142.81M · vs all stocks (USD)
52-Week Low
5.53CNYUpdated Aug 20, 202652-Week High
8.62CNYUpdated Aug 20, 202652-Week Change
-17.34%vs all stocks
Beta
0.2380xvs all stocks
50-Day MA
6.19CNYUpdated Aug 20, 2026200-Day MA
7.51CNYUpdated Aug 20, 2026Avg 10-Day Volume
5.20MSharesUpdated Aug 20, 2026Avg 30-Day Volume
6.53MSharesUpdated Aug 20, 2026Diluted EPS (TTM)
0.2200CNYUpdated Aug 20, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
How is this stock valued?
Price Below Mean With Profitability And Book Value
Price sits well below its yearly mean, on three profitable years and rising book value.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 9.8: safe zoneNotable
Altman Z-Score: 9.80
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Neumora Therapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Immuneering Corporation
Tier 1ProductionApproval-Gated PipelineRule
908 Devices Inc.
Tier 1ProductionApproval-Gated PipelineRule
JBM
Tier 1ProductionApproval-Gated PipelineRuleFlow
Hikal Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Essex Bio-Technology Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Foghorn Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Jiangsu GDK Biotechnology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Cutia Therapeutics Limited
Tier 1ProductionApproval-Gated PipelineRuleRisk
CytoDyn Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Companies that share active interpretations — structural patterns currently present in both stocks.
SmartGen Zhengzhou Technology Co., Ltd.
2 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesPrice Below Mean With Profitability And Book Value
Anhui XDLK Microsystems Co., Ltd.
2 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesPrice Below Mean With Profitability And Book Value
Motomotion China Corp.
2 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesPrice Below Mean With Profitability And Book Value